VEXT.CN
Vext Science Inc
Price:  
0.25 
CAD
Volume:  
133,000.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VEXT.CN EV/EBITDA

180.2%
Upside

As of 2026-03-16, the EV/EBITDA ratio of Vext Science Inc (VEXT.CN) is 5.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VEXT.CN's latest enterprise value is 113.31 mil CAD. VEXT.CN's TTM EBITDA according to its financial statements is 22.47 mil CAD. Dividing these 2 quantities gives us the above VEXT.CN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 6.8x - 11.3x 9.2x
Forward P/E multiples 4.3x - 8.9x 6.6x
Fair Price 0.32 - 1.06 0.70
Upside 26.8% - 324.9% 180.2%
0.25 CAD
Stock Price
0.70 CAD
Fair Price

VEXT.CN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-03-11 3.69
2026-03-10 3.74
2026-03-09 3.69
2026-03-06 3.65
2026-03-05 3.65
2026-03-03 3.69
2026-03-02 3.55
2026-02-27 3.55
2026-02-26 3.69
2026-02-25 3.69
2026-02-24 3.69
2026-02-23 3.69
2026-02-20 3.87
2026-02-19 3.97
2026-02-18 3.87
2026-02-17 4.01
2026-02-13 3.97
2026-02-12 3.92
2026-02-11 3.87
2026-02-10 3.92
2026-02-09 3.97
2026-02-06 3.97
2026-02-05 3.97
2026-02-04 3.97
2026-02-03 4.06
2026-02-02 4.06
2026-01-30 4.06
2026-01-29 4.06
2026-01-28 4.06
2026-01-27 3.97
2026-01-26 3.97
2026-01-22 4.01
2026-01-20 3.92
2026-01-19 3.97
2026-01-16 3.87
2026-01-15 3.92
2026-01-14 3.87
2026-01-13 3.87
2026-01-12 3.97
2026-01-09 3.74
2026-01-08 3.87
2026-01-07 3.60
2026-01-06 3.60
2026-01-05 3.55
2026-01-02 3.65
2025-12-31 3.74
2025-12-30 3.69
2025-12-29 3.83
2025-12-24 3.97
2025-12-23 4.10